AGED Diagnostics
Washington
About AGED Diagnostics
AGE Diagnostics develops diagnostic tools for nonalcoholic steatohepatitis (NASH, liver disease) and fibrosis (liver scarring). AGED tools can simultaneously stage fibrosis and distinguish benign from severe liver disease (liver scarring). This method measures the concentration of target biomarkers (genetic signatures) in circulation using a targeted genomic sequencing assessment. When biomarkers are detected over a specific quantity, liver disease (NASH) and/or fibrosis are diagnosed.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $450.0K
- Funding stage: Seed
- Last round: Seed (Aug 2025)
- Website: ageddiagnostics.com
- Phone: (617) 777-7971
Industries & Categories
Health Care, Medical, Medical Device
Canonical: https://fsome.com/organization/aged-diagnostics-107730 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.